P049 Genomic landscape of the PI3K pathway and cell-cycle pathway in ER+ BC: a treatment strategy

Polev De, B Leyland-Jones(Amgen (United States)), Nrisingha Dey(Ramakrishna Mission Vivekananda Educational and Research Institute), Christopher S. Williams(Vanderbilt University), Benjamin D. Solomon(National Human Genome Research Institute), K. Williams, Jennifer Carlson(Avera Health), Yan-Gang Sun(Chinese Academy of Sciences), J. Klein, Amy Krie(Amgen (United States))
The Breast
March 1, 2015
10.1016/s0960-9776(15)70099-8
Cited by 0

Related Papers

Molecular basis of human hypertension: Role of angiotensinogen
|Cell|1992|1.9k
Sensitive and specific multi-cancer detection and localization using methylation signatures in cell-free DNA
|Annals of Oncology|2020|1.5k
Molecular profiling of cancer patients enables personalized combination therapy: the I-PREDICT study
|Nature Medicine|2019|726
Consequences of Driving Cessation: Decreased Out-of-Home Activity Levels
|The Journals of Gerontology Series B|2000|725
The Effect of Falls and Fall Injuries on Functioning in Community-Dwelling Older Persons
|The Journals of Gerontology Series A|1998|672